Microalbuminuria is positively associated with usual dietary saturated fat intake and negatively associated with usual dietary protein intake in people with insulin-dependent diabetes mellitus

American Journal of Clinical Nutrition

Volumn 67, Issue 1, 1998, Pages 50-57

  Riley, Malcolm D ^a   Dwyer, Terence ^b  

^a The Menzies Foundation   (Australia)

^b NONE

Author keywords

Carbohydrate intake; Humans; IDDM; Insulin dependent diabetes mellitus; Insulin Treated Diabetes Register; Microalbuminuria; Protein intake; Saturated fat; Tasmania

Indexed keywords

SATURATED FATTY ACID;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; PROTEIN INTAKE; PROTEINURIA;

EID: 0031974394     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.1.50     Document Type: Article

References (57)

1. Riley MD, McCarty DJ, Couper DJ, Humphrey ARG, Dwyer T, Zimmet PZ. The 1984 Tasmanian Insulin-Treated Diabetes Mellitus Prevalence Cohort: an 8 1/2 year mortality follow-up investigation. Diabetes Res Clin Pract 1995;29:27-35.
2. Green A, Borch-Johnsen K, Andersen PK, et al. Relative mortality of type 1 (insulin-dependent) diabetes in Denmark 1933 to 1981. Diabetologia 1985;28:339-42.
3. Leslie RDG, Elliott RB. Early environmental events as a cause of IDDM-evidence and implications. Diabetes 1994;43:843-50.
4. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985;28:590-6.
5. Borch-Johnsen K, Kreiner S. Proteinuria: value as a predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 1987;294:1651-4.
6. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-41.
7. Beilin J, Knuiman MW, Stanton KG, Divitini ML, McCann VJ. Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality. Aust N Z J Med 1996;26:519-25.
8. Damsgaard EM, Froland A, Jorgenson OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990;300:297-300.
9. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type 1 diabetes. Am J Med 1985;78:785-94.
10. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
11. Gilbert RE, Cooper ME, McNally PG, et al. Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus. Diabetic Med 1994;11:636-45.
12. Viberti G, Mogenson CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271:275-9.
13. Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. Br Med J 1991;303:81-7.
14. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983;25:496-501.
15. Klein R, Klein BEK, Moss SE. The incidence of gross proteinuria in people with insulin dependent diabetes mellitus. Arch Intern Med 1991;151:1344-8.
16. Koefoed-Enevoldson A, Borch-Johnson K, Kreiner S, Nerup J, Deckert T. Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 1987;36:205-9.
17. Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990;39:1116-24.
18. Muhlhauser I, Sawicki P, Berger M, Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin dependent) diabetes. Diabetologia 1986;19:500-2.
19. Couper JJ, Staples AJ, Cocciolone R, Nairn J, Badcock N, Henning P. Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabetic Med 1994;11:666-9.
20. Winocour PH, Durrington PN, Ishola M, Anderson DC, Cohen H. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus, Br Med J 1987;294:1648-51.
21. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 1989;298:487-90.
22. Watts GF, Gregory L, Naomova R, Kubal C, Shaw KM. Nutrient intake in insulin dependent diabetic patients with incipient nephropathy. Eur J Clin Nutr 1988;42:697-702.
23. Kalk WJ, Osier C, Constable J, Kruger M, Panz V. Influence of dietary protein on glomerular filtration and urinary albumin excretion in insulin-dependent diabetes. Am J Clin Nutr 1992;56:169-73.
24. Brenner BM, Meyer TW, Hostetter TH. Dietary intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-9.
25. Hartroft WS. Fat emboli in glomerular capillaries of choline-deficient rats and of patients with diabetic glomerulosclerosis. Am J Pathol 1955;31:381-97.
26. Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982;11:1309-11.
27. Australian Bureau of Statistics. Causes of death in Australia 1992. Canberra, Australia: ABS, 1993. (ABS publication no. 3303.0.)
28. King H, Dixon J, Senator G, Schoonveldt M, Zimmet P. Type 1 (insulin-dependent) diabetes in Tasmania: prevalence and apparent regional differences. Diabetologia 1988;31:93-7.
29. King H, Senator G, Zimmet P, Harris A. The Tasmanian Insulin- Treated Diabetes Register: inception and progress in the first twelve months. Med J Aust 1986;144:414-6.
30. Izzo G, Grillo F, Murado E. Improved method for determination of high- density-lipoprotein cholesterol 1. Isolation of high density lipoproteins by use of polyethylene glycol 6000. Clin Chem 1981;27:371-5.
31. Bowers LD, Wong ET. Kinetic serum creatinine assays II. A critical evaluation and review. Clin Chem 1980;26:555-61.
32. Baghurst KI, Record SJ. A computerised dietary analysis system for use with diet diaries or food frequency questionnaires. Community Health Stud 1984;7:11-8.
33. Paul AA, Southgate DAT. McCance and Widdowson's the composition of foods. London: Her Majesty's Stationery Office, 1978.
34. Willen WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
35. Riley MD, Blizzard CL. Comparative validity of a food frequency questionnaire for adults with insulin dependent diabetes mellitus. Diabetes Care 1995;18:1249-54.
36. Mogensen CE. Prediction of clinical diabetic nephropathy in IDDM patients - alternatives to microalbuminuria? Diabetes 1990;39: 761-7.
37. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989;79:340-9.
38. SAS Institute Inc. SAS STAT guide for personal computers, version 6. Cary, NC: SAS Institute Inc, 1985.
39. Microalbuminuria Collaborative Study Group, United Kingdom. Risk factors for the development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Br Med J 1993; 306:1235-9.
40. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994;43:426-9.
41. Forsblom CM, Groop PH, Ekstrand A, Groop LC. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. Br Med J 1992;305:1051-3.
42. Messent JWC, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992;41:836-9.
43. Mathinesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991;303:81-7.
44. Cohen D, Dodds R, Viberti G. Effect of protein restriction in insulin dependent diabetics at risk of nephropathy. Br Med J 1987; 294:795-8.
45. Bending JJ, Dodds RA, Keen H, Viberti G. Renal response to restricted protein intake in diabetic nephropathy. Diabetes 1988;37:1641-6.
46. Evanoff GV, Thompson C, Brown J, Weinmann E. Prolonged dietary protein restriction in diabetic nephropathy. Arch Intern Med 1989;149:1129-33.
47. Dullaart RPF, Beusekamp BJ, Meijer S, Hoogenberg K, Van Doormaal JJ, Sluiter WJ. Long term effects of linoleic-acid-enriched diet on albuminuria and lipid levels in type 1 (insulin-dependent) diabetic patients with elevated urinary albumin excretion. Diabetologia 1992;35:165-72.
48. American Diabetes Association. Clinical practice recommendations. Diabetes Care 1993;16(suppl 2):22-9.
49. Dullaart RPF, Beusekamp BJ, Meijer S, Hoogenberg K, Van Doormaal JJ, Sluiter WJ. Long term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 1993;16:483-92.
50. Brace LD, Gittler-Buffa C, Miller GJ, et al. Factor VII coagulant activity and cholesterol changes in premenopausal women consuming a long-term cholesterol-lowering diet. Arterioscler Thromb 1994;14:1284-9.
51. Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb 1994;14:214-22.
52. Smith U. Carbohydrates, fat and insulin action. Am J Clin Nutr 1994;59(suppl):686S-9S.
53. Hunnicutt JW, Hardy RW, Williford J, McDonald JM. Saturated fatty acid-induced resistance in rat adipocytes. Diabetes 1994;43:540-5.
54. Rasmussen O, Lauszus FF, Christiansen C, Thomsen C, Hermansen K. Differential effects of saturated and monounsaturated fat on blood glucose and insulin response in subjects with non-insulin- dependent diabetes mellitus. Am J Clin Nutr 1996;63:249-53.
55. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti GC. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993;342:883-7.
56. Van Amelsvoort JM, Van der Beek A, Stam JJ. Effect of the type of dietary fatty acid on the insulin receptor function in rat epididymal fat cells. Ann Nutr Metab 1986;30:273-80.
57. Karhapaa P, Malkki M, Laakso M. Isolated low HDL cholesterol -an insulin resistant state. Diabetes 1994;43:411-7.